ETHZ
HealthcareETHZilla Corporation
$5.36
+$0.25 (+4.89%)
Jan 5, 2026
Price History (1Y)
Analysis
ETHZilla Corporation is a biotechnology company in the healthcare sector with a market capitalization of $101.91 million. The company's revenue for the trailing twelve months (TTM) is $4.11 million. The financial health of ETHZilla Corporation reveals significant challenges. The company reports a net income loss of $224,528,976 and an EBITDA loss of $226,656,496 over the TTM period. This is accompanied by a negative free cash flow of $441,101,376 and a debt-to-equity ratio of 122.83. Notably, the company's operating margin stands at -5364.6%, indicating substantial operational losses. In terms of valuation context, ETHZilla Corporation has a price to book ratio of 0.19 and a price to sales ratio of 24.79. The forward P/E ratio is not available, but the current price metrics indicate a significant drop from the 52-week high of $174.60 to the 52-week low of $4.86.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About ETHZilla Corporation
ETHZilla Corporation operates as a technology company in the decentralized finance industry. It connects financial institutions, businesses and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations. The company, through its proprietary protocol implementations, facilitates DeFi transactions and asset digitization across multiple Layer 2 Ethereum networks. The Company offers tokenization solutions, DeFi protocol integration, blockchain analytics, traditional-to-digital asset conversion gateways, and other decentralized finance services. The company was formerly known as 180 Life Sciences Corp. and changed its name to ETHZilla Corporation in August 2025. ETHZilla Corporation is headquartered in Palm Beach, Florida.
Visit website →Key Statistics
- Market Cap
- $101.91M
- P/E Ratio
- N/A
- 52-Week High
- $174.60
- 52-Week Low
- $4.86
- Avg Volume
- 1.23M
- Beta
- 1.13
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States